Core Insights - Ethos partners with Aflac to enhance access to supplemental health insurance through a digital platform, starting with Aflac's cancer insurance offerings [1][2] Company Overview - Ethos is a leading life insurance technology company focused on democratizing access to life insurance and transforming the insurance experience through a digital-first approach [6] - Aflac is a Fortune 500 company recognized as the No. 1 provider of supplemental health insurance in the U.S. and a leading provider in Japan for cancer and medical insurance [7] Partnership Details - The collaboration allows Aflac to utilize Ethos's technology and distribution network, providing a seamless digital experience for customers to access cancer insurance [2][4] - Aflac's cancer insurance offers cash benefits directly to policyholders for medical costs and ongoing expenses during treatment, with no deductibles and straightforward claims processing [3][4] Strategic Implications - The partnership underscores Ethos's role as a key distribution and technology partner for top-rated insurers, enhancing the accessibility and affordability of insurance products for families [4][5] - Ethos aims to empower insurance carriers to modernize distribution and make essential protection simple and affordable for millions [5]

Core Insights - Aflac Incorporated reported a significant decline in total revenues for Q1 2025, amounting to $3.4 billion, down from $5.4 billion in Q1 2024, primarily due to net investment losses of $963 million compared to net gains of $951 million in the previous year [1][20][27] - Net earnings for the first quarter were $29 million, or $0.05 per diluted share, a drastic decrease from $1.9 billion, or $3.25 per diluted share, in the same quarter last year [1][20][27] Financial Performance - Net investment losses in Q1 2025 were $963 million, driven by losses on derivatives and foreign currency activities, as well as a decrease in the fair value of equity securities [2][3] - Adjusted earnings for the quarter were $906 million, a decrease of 5.7% from $961 million in Q1 2024, with adjusted earnings per diluted share remaining flat at $1.66 [3][27] - Shareholders' equity increased to $26.3 billion, or $48.55 per share, compared to $23.5 billion, or $41.27 per share, a year earlier [5][21] Segment Performance - Aflac Japan's net earned premiums in yen decreased by 5.0% to ¥256.5 billion, while in dollar terms, net earned premiums fell by 7.4% to $1.7 billion [7][8] - Aflac U.S. saw a 1.8% increase in net earned premiums to $1.5 billion, with total adjusted revenues up 1.3% to $1.7 billion [10][11] Sales and New Products - Total new annualized premium sales in Japan increased by 12.6% to ¥14.1 billion, reflecting strong sales of new products [9] - In the U.S., sales increased by 3.5% to $309 million, driven by group product sales [11] Capital Management - The board declared a second-quarter dividend of $0.58 per share, with $900 million deployed for share repurchases in Q1 2025 [13][17] - The company maintained a strong focus on capital and cash flow generation while managing liquidity and capital effectively [17] Outlook and Strategy - The CEO expressed satisfaction with the adjusted earnings and premium persistency rates in both Japan and the U.S., emphasizing a focus on profitable growth and improved underwriting discipline [14][16]